Now showing items 1-4 of 4

    • Epidemiology of hepatitis B virus infection in India 

      Tandon, BN; Tandon, A; Acharya, KS (Department of Medicine, College of Health Sciences, University of Nairobi, 1996)
      The average estimated carrier rate of hepatitis B virus (HBV) in India is 4%, with a total pool of approximately 36 million carriers. Wide variations in social, economic, and health factors in different regions may explain ...
    • Fulminant hepatitis in a tropical population: clinical course, cause, and early predict 

      Acharya, KS; Dasarathy, S; Kumer, TL; Sushma, S; Prasanna, KS; Tandon, A; Sreenivas, V; Nijhawan, S; Panda, SK; Nanda, SK; Irshad, M; Joshi, YK; Duttagupta, S; Tandon, RK; Tandon, BN (Department of Medicine, College of Health Sciences, University of Nairobi, 1996)
      The profiles of patients with fulminant hepatic failure (FHF) from developing countries have not been reported earlier. The current study was conducted prospectively, at a single tertiary care center in India, to document ...
    • Pathology of subacute hepatic failure 

      Nayak, NC; Dutta, Gupta S; Tandon, A; Dasarathy, S; Acharya, KS (Department of Medicine, College of Health Sciences, University of Nairobi, 1993)
    • A preliminary open trial on interferon stimulator (SNMC) derived from Glycyrrhiza glabra in the treatment of subacute hepatic failure 

      Acharya, KS; Dasarathy, S; Tandon, A; Joshi, YK; Tandon, BN (Department of Medicine, College of Health Sciences, University of Nairobi, 1993)
      The efficacy of the interferon stimulator named Stronger Neo Minophagen-C (SNMC) derived form the plant G. glabra was studied at a dose of 40 or 100 ml daily for 30 days followed by thrice weekly intravenously for 8 wk in ...